Armenia vs Sur: New cases tested for RR-/MDR-TB
Armenia
100.0%
in 2024
Sur
97.0%
in 2024
Armenia rank
1st
Sur rank
2nd
New cases tested for RR-/MDR-TB over time
- Armenia
- Sur
How they compare
Armenia currently reports 100.0% against 97.0% in Sur, a difference of 3.0%.
The two have swapped places 4 times across 18 shared years of data; in 2005 it was Armenia ahead.
Armenia ranks 1st and Sur ranks 2nd of 192 countries.
Armenia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Armenia | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.7% | 32.2% | 57.4% | Armenia |
| 2010s | 93.6% | 62.2% | 31.3% | Armenia |
| 2020s | 99.8% | 97.2% | 2.6% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Armenia or Sur?
- Armenia, at 100.0% against 97.0% in Sur as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Armenia and Sur?
- 3.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Sur?
- 18 years are reported by both, from 2005 to 2024.
- How do Armenia and Sur rank globally for new cases tested for rr-/mdr-tb?
- Armenia ranks 1st and Sur ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.